Related Experiment Video

Updated: Jun 3, 2026

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
09:17

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

Actin disruption inhibits hypoxia inducible factor-1α expression via inactivity of Mdm2-mediated p70S6K

Ik Jae Shin1, Bae Keun Park, Yong-Tae Ahn

  • 1Joint Research Center of Pusan National University-Fraunhofer IGB, Busan 609-735, Korea.

Molecular Medicine Reports
|April 8, 2011
PubMed

Insights

Disrupting actin dynamics in cancer cells reduces hypoxia-inducible factor-1α (HIF-1α) expression via translational control, not proteasomal degradation. This suggests novel therapeutic strategies targeting actin dysfunction for cancer treatment.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Molecular Oncology

Background:

  • The actin cytoskeleton is crucial for tumor cell migration, adhesion, and metastasis.
  • Actin destabilization impacts cancer progression and hypoxia-inducible factor-1α (HIF-1α) activity.
  • The precise mechanisms linking actin disruption to HIF-1α regulation remain unclear.

Purpose of the Study:

  • To investigate the relationship between actin dynamics and HIF-1α expression in cancer cells.
  • To elucidate the signaling pathways involved in HIF-1α regulation following actin disruption.
  • To explore the potential of targeting actin dynamics as an anticancer strategy.

Main Methods:

  • Inhibition of actin polymerization and depolymerization.
  • Assessment of HIF-1α expression levels.
  • Analysis of proteasomal degradation pathways.
  • Investigation of p70S6K translational signaling.
  • Evaluation of p53 activation status.

Main Results:

  • Inhibition of actin dynamics attenuates HIF-1α expression independently of proteasomal degradation.
  • Actin disruption inactivates HIF-1α translational expression through p70S6K signaling.
  • This regulation occurs independently of p53 activation.

Conclusions:

  • Actin cytoskeleton dynamics play a significant role in regulating HIF-1α expression at the translational level.
  • Targeting actin dysfunction offers a potential novel therapeutic approach for cancer, independent of p53.
  • Further research into actin-HIF-1α interactions could yield new chemotherapeutic strategies.

More Related Videos

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

Induction and Testing of Hypoxia in Cell Culture07:01

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...